Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer ; volume:44 ; number:10 ; day:19 ; month:6 ; year:2017 ; pages:1671-1678 ; date:9.2017
European journal of nuclear medicine and molecular imaging ; 44, Heft 10 (19.6.2017), 1671-1678, 9.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Du, Yong
- Beteiligte Personen und Organisationen
-
Carrio, Ignasi
Vincentis, Giuseppe De
Fanti, Stefano
Ilhan, Harun
Mommsen, Caroline
Nitzsche, Egbert
Sundram, Francis
Vogel, Wouter
Oyen, Wim
Lewington, Val
SpringerLink (Online service)
- DOI
-
10.1007/s00259-017-3756-7
- URN
-
urn:nbn:de:1111-201710175295
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Du, Yong
- Carrio, Ignasi
- Vincentis, Giuseppe De
- Fanti, Stefano
- Ilhan, Harun
- Mommsen, Caroline
- Nitzsche, Egbert
- Sundram, Francis
- Vogel, Wouter
- Oyen, Wim
- Lewington, Val
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer